TTF1_HUMAN - dbPTM
TTF1_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID TTF1_HUMAN
UniProt AC Q15361
Protein Name Transcription termination factor 1
Gene Name TTF1
Organism Homo sapiens (Human).
Sequence Length 905
Subcellular Localization Nucleus. Nucleus, nucleolus.
Protein Description Multifunctional nucleolar protein that terminates ribosomal gene transcription, mediates replication fork arrest and regulates RNA polymerase I transcription on chromatin. Plays a dual role in rDNA regulation, being involved in both activation and silencing of rDNA transcription. Interaction with BAZ2A/TIP5 recovers DNA-binding activity..
Protein Sequence MEGESSRFEIHTPVSDKKKKKCSIHKERPQKHSHEIFRDSSLVNEQSQITRRKKRKKDFQHLISSPLKKSRICDETANATSTLKKRKKRRYSALEVDEEAGVTVVLVDKENINNTPKHFRKDVDVVCVDMSIEQKLPRKPKTDKFQVLAKSHAHKSEALHSKVREKKNKKHQRKAASWESQRARDTLPQSESHQEESWLSVGPGGEITELPASAHKNKSKKKKKKSSNREYETLAMPEGSQAGREAGTDMQESQPTVGLDDETPQLLGPTHKKKSKKKKKKKSNHQEFEALAMPEGSQVGSEVGADMQESRPAVGLHGETAGIPAPAYKNKSKKKKKKSNHQEFEAVAMPESLESAYPEGSQVGSEVGTVEGSTALKGFKESNSTKKKSKKRKLTSVKRARVSGDDFSVPSKNSESTLFDSVEGDGAMMEEGVKSRPRQKKTQACLASKHVQEAPRLEPANEEHNVETAEDSEIRYLSADSGDADDSDADLGSAVKQLQEFIPNIKDRATSTIKRMYRDDLERFKEFKAQGVAIKFGKFSVKENKQLEKNVEDFLALTGIESADKLLYTDRYPEEKSVITNLKRRYSFRLHIGRNIARPWKLIYYRAKKMFDVNNYKGRYSEGDTEKLKMYHSLLGNDWKTIGEMVARSSLSVALKFSQISSQRNRGAWSKSETRKLIKAVEEVILKKMSPQELKEVDSKLQENPESCLSIVREKLYKGISWVEVEAKVQTRNWMQCKSKWTEILTKRMTNGRRIYYGMNALRAKVSLIERLYEINVEDTNEIDWEDLASAIGDVPPSYVQTKFSRLKAVYVPFWQKKTFPEIIDYLYETTLPLLKEKLEKMMEKKGTKIQTPAAPKQVFPFRDIFYYEDDSEGEDIEKESEGQAPCMAHACNSSTLGGQGRWII
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
12PhosphorylationSSRFEIHTPVSDKKK
CCCEEECCCCCCCCC
30.9230266825
15PhosphorylationFEIHTPVSDKKKKKC
EEECCCCCCCCCCCC
44.9430266825
40PhosphorylationSHEIFRDSSLVNEQS
CHHHHCCHHHHCCHH
22.7019691289
41PhosphorylationHEIFRDSSLVNEQSQ
HHHHCCHHHHCCHHH
40.4025159151
47PhosphorylationSSLVNEQSQITRRKK
HHHHCCHHHHHHHHH
19.8520068231
50PhosphorylationVNEQSQITRRKKRKK
HCCHHHHHHHHHHHH
19.4520068231
64PhosphorylationKDFQHLISSPLKKSR
HHHHHHHCCCCHHHC
32.0629255136
65PhosphorylationDFQHLISSPLKKSRI
HHHHHHCCCCHHHCC
27.5329255136
70PhosphorylationISSPLKKSRICDETA
HCCCCHHHCCCHHHC
25.8728111955
76PhosphorylationKSRICDETANATSTL
HHCCCHHHCCCCHHH
16.3830576142
80PhosphorylationCDETANATSTLKKRK
CHHHCCCCHHHHHHH
23.2725159151
81PhosphorylationDETANATSTLKKRKK
HHHCCCCHHHHHHHH
29.3621815630
82PhosphorylationETANATSTLKKRKKR
HHCCCCHHHHHHHHH
37.9421815630
84UbiquitinationANATSTLKKRKKRRY
CCCCHHHHHHHHHCC
51.09-
85UbiquitinationNATSTLKKRKKRRYS
CCCHHHHHHHHHCCC
72.98-
92PhosphorylationKRKKRRYSALEVDEE
HHHHHCCCCEEECCC
25.2722468782
115PhosphorylationDKENINNTPKHFRKD
CHHHCCCCCCHHCCC
29.2628348404
144AcetylationPRKPKTDKFQVLAKS
CCCCCCCHHHHHHHH
42.8225953088
144UbiquitinationPRKPKTDKFQVLAKS
CCCCCCCHHHHHHHH
42.82-
150UbiquitinationDKFQVLAKSHAHKSE
CHHHHHHHHHCCHHH
38.32-
161PhosphorylationHKSEALHSKVREKKN
CHHHHHHHHHHHHHH
33.42-
177PhosphorylationKHQRKAASWESQRAR
HHHHHHHHHHHHHHH
35.9125159151
213PhosphorylationEITELPASAHKNKSK
CCCCCCCHHCCCCCC
29.0325159151
226PhosphorylationSKKKKKKSSNREYET
CCCCCCCCCCHHHHH
41.5528555341
227PhosphorylationKKKKKKSSNREYETL
CCCCCCCCCHHHHHH
49.1125159151
231PhosphorylationKKSSNREYETLAMPE
CCCCCHHHHHHHCCC
15.8118669648
233PhosphorylationSSNREYETLAMPEGS
CCCHHHHHHHCCCCH
20.9320068231
240PhosphorylationTLAMPEGSQAGREAG
HHHCCCCHHHHHHCC
18.3917525332
248PhosphorylationQAGREAGTDMQESQP
HHHHHCCCCCCCCCC
35.0323663014
253PhosphorylationAGTDMQESQPTVGLD
CCCCCCCCCCCCCCC
25.2723663014
256PhosphorylationDMQESQPTVGLDDET
CCCCCCCCCCCCCCC
21.4023663014
263PhosphorylationTVGLDDETPQLLGPT
CCCCCCCCCHHCCCC
24.2723401153
270PhosphorylationTPQLLGPTHKKKSKK
CCHHCCCCCCCCCCC
44.5223401153
297PhosphorylationALAMPEGSQVGSEVG
HHHCCCCCCCCCCCC
21.74-
301PhosphorylationPEGSQVGSEVGADMQ
CCCCCCCCCCCCCHH
30.19-
357PhosphorylationPESLESAYPEGSQVG
CHHHHHHCCCCCCCC
15.88-
361PhosphorylationESAYPEGSQVGSEVG
HHHCCCCCCCCCCCC
21.74-
365PhosphorylationPEGSQVGSEVGTVEG
CCCCCCCCCCCEECC
30.19-
398AcetylationKRKLTSVKRARVSGD
HCCCCCCEEEECCCC
39.867708271
403PhosphorylationSVKRARVSGDDFSVP
CCEEEECCCCCCCCC
30.8329255136
408PhosphorylationRVSGDDFSVPSKNSE
ECCCCCCCCCCCCCC
39.8629255136
434UbiquitinationAMMEEGVKSRPRQKK
HHHCCCCCCCCCHHH
52.16-
449AcetylationTQACLASKHVQEAPR
HHHHHHHHHHHHCCC
42.0323749302
449UbiquitinationTQACLASKHVQEAPR
HHHHHHHHHHHHCCC
42.03-
468PhosphorylationNEEHNVETAEDSEIR
CCCCCCCCCCCCCCE
30.9427732954
472PhosphorylationNVETAEDSEIRYLSA
CCCCCCCCCCEEEEC
26.8225850435
476PhosphorylationAEDSEIRYLSADSGD
CCCCCCEEEECCCCC
15.6323927012
478PhosphorylationDSEIRYLSADSGDAD
CCCCEEEECCCCCCC
22.5423927012
481PhosphorylationIRYLSADSGDADDSD
CEEEECCCCCCCCCC
37.9923927012
487PhosphorylationDSGDADDSDADLGSA
CCCCCCCCCCCHHHH
34.9329255136
493PhosphorylationDSDADLGSAVKQLQE
CCCCCHHHHHHHHHH
36.8730266825
506UbiquitinationQEFIPNIKDRATSTI
HHHCCCCHHHHHHHH
48.04-
510PhosphorylationPNIKDRATSTIKRMY
CCCHHHHHHHHHHHH
27.5728634120
514UbiquitinationDRATSTIKRMYRDDL
HHHHHHHHHHHHHHH
31.07-
528MethylationLERFKEFKAQGVAIK
HHHHHHHHHHCEEEE
40.67115979431
528UbiquitinationLERFKEFKAQGVAIK
HHHHHHHHHHCEEEE
40.67-
535UbiquitinationKAQGVAIKFGKFSVK
HHHCEEEEECCCCHH
38.02-
538UbiquitinationGVAIKFGKFSVKENK
CEEEEECCCCHHHCH
37.28-
542UbiquitinationKFGKFSVKENKQLEK
EECCCCHHHCHHHHH
55.14-
549UbiquitinationKENKQLEKNVEDFLA
HHCHHHHHHHHHHHH
74.92-
565UbiquitinationTGIESADKLLYTDRY
HCCCCHHHHHHCCCC
39.86-
568PhosphorylationESADKLLYTDRYPEE
CCHHHHHHCCCCCHH
19.6130177828
569PhosphorylationSADKLLYTDRYPEEK
CHHHHHHCCCCCHHH
17.6130177828
572PhosphorylationKLLYTDRYPEEKSVI
HHHHCCCCCHHHHHH
20.1530177828
583UbiquitinationKSVITNLKRRYSFRL
HHHHHHHCHHEEEEE
36.58-
587PhosphorylationTNLKRRYSFRLHIGR
HHHCHHEEEEEEECC
11.3329496963
617UbiquitinationMFDVNNYKGRYSEGD
HCCCCCCCCCCCCCC
38.75-
621PhosphorylationNNYKGRYSEGDTEKL
CCCCCCCCCCCHHHH
33.4725159151
627UbiquitinationYSEGDTEKLKMYHSL
CCCCCHHHHHHHHHH
56.34-
629UbiquitinationEGDTEKLKMYHSLLG
CCCHHHHHHHHHHHC
48.78-
640UbiquitinationSLLGNDWKTIGEMVA
HHHCCCHHHHHHHHH
32.88-
650PhosphorylationGEMVARSSLSVALKF
HHHHHHHHHHHHHHH
21.0720860994
652PhosphorylationMVARSSLSVALKFSQ
HHHHHHHHHHHHHHH
13.8029759185
658PhosphorylationLSVALKFSQISSQRN
HHHHHHHHHHHCCCC
25.6429759185
661PhosphorylationALKFSQISSQRNRGA
HHHHHHHHCCCCCCC
16.8729759185
662PhosphorylationLKFSQISSQRNRGAW
HHHHHHHCCCCCCCC
34.4929759185
671UbiquitinationRNRGAWSKSETRKLI
CCCCCCCHHHHHHHH
41.43-
687UbiquitinationAVEEVILKKMSPQEL
HHHHHHHHHCCHHHH
34.99-
688AcetylationVEEVILKKMSPQELK
HHHHHHHHCCHHHHH
40.9620167786
688UbiquitinationVEEVILKKMSPQELK
HHHHHHHHCCHHHHH
40.96-
690PhosphorylationEVILKKMSPQELKEV
HHHHHHCCHHHHHHH
32.1025159151
695UbiquitinationKMSPQELKEVDSKLQ
HCCHHHHHHHHHHHH
55.74-
700AcetylationELKEVDSKLQENPES
HHHHHHHHHHHCHHH
50.1320167786
700SumoylationELKEVDSKLQENPES
HHHHHHHHHHHCHHH
50.1328112733
700UbiquitinationELKEVDSKLQENPES
HHHHHHHHHHHCHHH
50.13-
710PhosphorylationENPESCLSIVREKLY
HCHHHHHHHHHHHHH
24.3025159151
738UbiquitinationTRNWMQCKSKWTEIL
HCCHHHCHHHHHHHH
37.87-
740UbiquitinationNWMQCKSKWTEILTK
CHHHCHHHHHHHHHH
43.56-
747UbiquitinationKWTEILTKRMTNGRR
HHHHHHHHHHCCCCC
36.41-
765UbiquitinationGMNALRAKVSLIERL
CHHHHHHHHHHHHHH
26.39-
808UbiquitinationQTKFSRLKAVYVPFW
HHHHHHCEEEEECCC
34.39-
818UbiquitinationYVPFWQKKTFPEIID
EECCCCCCCHHHHHH
40.05-
838UbiquitinationTLPLLKEKLEKMMEK
CHHHHHHHHHHHHHH
61.43-
846UbiquitinationLEKMMEKKGTKIQTP
HHHHHHHCCCCCCCC
59.51-
857AcetylationIQTPAAPKQVFPFRD
CCCCCCCCCEECCCC
55.137339563
857UbiquitinationIQTPAAPKQVFPFRD
CCCCCCCCCEECCCC
55.13-
867PhosphorylationFPFRDIFYYEDDSEG
ECCCCEEEEECCCCC
13.2823403867
868PhosphorylationPFRDIFYYEDDSEGE
CCCCEEEEECCCCCC
11.3526657352
872PhosphorylationIFYYEDDSEGEDIEK
EEEEECCCCCCCCCH
60.8825159151
881PhosphorylationGEDIEKESEGQAPCM
CCCCCHHCCCCCCCH
59.0825002506
894PhosphorylationCMAHACNSSTLGGQG
CHHHHCCCCCCCCCC
25.2825627689
895PhosphorylationMAHACNSSTLGGQGR
HHHHCCCCCCCCCCC
17.4125627689
896PhosphorylationAHACNSSTLGGQGRW
HHHCCCCCCCCCCCC
29.2825627689

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
-KUbiquitinationE3 ubiquitin ligaseMDM2Q00987
PMID:22383580

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of TTF1_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of TTF1_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
CAVN1_HUMANPTRFphysical
9582279
KAT2B_HUMANKAT2Bphysical
11250901
BAZ2A_HUMANBAZ2Aphysical
15292447
MDM2_HUMANMDM2physical
22383580
CDN2A_HUMANCDKN2Aphysical
22383580
ARF_HUMANCDKN2Aphysical
22383580

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of TTF1_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-476; SER-481 ANDSER-487, AND MASS SPECTROMETRY.
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-476; SER-481 ANDSER-487, AND MASS SPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-65; SER-403; SER-478;SER-481 AND SER-487, AND MASS SPECTROMETRY.
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis.";
Wang B., Malik R., Nigg E.A., Korner R.;
Anal. Chem. 80:9526-9533(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-41 AND SER-47, AND MASSSPECTROMETRY.
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage.";
Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
Science 316:1160-1166(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-240, AND MASSSPECTROMETRY.
"Phosphoproteome analysis of the human mitotic spindle.";
Nousiainen M., Sillje H.H.W., Sauer G., Nigg E.A., Koerner R.;
Proc. Natl. Acad. Sci. U.S.A. 103:5391-5396(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-872, AND MASSSPECTROMETRY.

TOP